| Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT) (NCT01518153) | M.D. Anderson Cancer Center | 2012-02-01 |
| Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia (NCT01505699) | Eastern Cooperative Oncology Group | 2012-01-06 |
| PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT01500733) | National Heart, Lung, and Blood Institute (NHLBI) | 2012-01-05 |
| Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia (NCT01385150) | Eastern Cooperative Oncology Group | 2012-01-03 |
| Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG (NCT01390402) | M.D. Anderson Cancer Center | 2012-01-01 |
| Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia (NCT01520246) | Children's Oncology Group | 2012-01-01 |
| Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation (NCT01517347) | Peking University People's Hospital | 2012-01-01 |
| Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL) (NCT01446133) | M.D. Anderson Cancer Center | 2011-12-12 |
| Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia (NCT01500499) | Children's Oncology Group | 2011-12-01 |
| SB1518 for Patients With Myelodysplastic Syndrome (MDS) (NCT01436084) | M.D. Anderson Cancer Center | 2011-12-01 |
| S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin (NCT01503541) | SWOG Cancer Research Network | 2011-12-01 |
| Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection (NCT01501708) | Shanghai Jiao Tong University School of Medicine | 2011-12-01 |
| Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS) (NCT01444742) | M.D. Anderson Cancer Center | 2011-11-16 |
| Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers (NCT01240525) | University College, London | 2011-11-01 |
| Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia (NCT01380756) | Amgen | 2011-10-04 |
| S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia (NCT01434329) | SWOG Cancer Research Network | 2011-10-01 |
| Pegasys in Patients With Chronic Myeloid Leukemia (CML) (NCT01392170) | M.D. Anderson Cancer Center | 2011-10-01 |
| Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923) (NCT01357655) | Bristol-Myers Squibb | 2011-09-01 |
| Allogeneic Transplant in HIV Patients (BMT CTN 0903) (NCT01410344) | Medical College of Wisconsin | 2011-09-01 |
| AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia (NCT01431664) | Cancer Research UK | 2011-09-01 |
| Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment (NCT01421862) | National Cancer Institute (NCI) | 2011-09-01 |
| Study of Proteins in Promoting Chemotherapy Resistance in Samples From Patients With Acute Myeloid Leukemia (NCT01419496) | Children's Oncology Group | 2011-09-01 |
| CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant (NCT01049854) | New York Medical College | 2011-09-01 |
| Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid Leukemia (NCT01438138) | Children's Oncology Group | 2011-09-01 |
| Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23) (NCT01253460) | M.D. Anderson Cancer Center | 2011-08-22 |
| Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia (NCT01421875) | Eastern Cooperative Oncology Group | 2011-08-17 |
| Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide (NCT01342289) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2011-08-01 |
| Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients (NCT01383473) | St. Jude Children's Research Hospital | 2011-08-01 |
| Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDS (NCT01442714) | Stanford University | 2011-08-01 |
| Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors (NCT01929720) | Ohio State University Comprehensive Cancer Center | 2011-08-01 |
| Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients (NCT01511289) | Il-Yang Pharm. Co., Ltd. | 2011-08-01 |
| Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy (NCT01258933) | M.D. Anderson Cancer Center | 2011-07-06 |
| Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) (NCT01272245) | M.D. Anderson Cancer Center | 2011-07-01 |
| Cell Samples From Patients With Leukemia (NCT01395628) | Children's Oncology Group | 2011-07-01 |
| Study of Long-Term Outcomes of Patients With Acute Lymphoblastic Leukemia Who Were Enrolled as Children on Clinical Trials EORTC-58741, EORTC-58831, EORTC-58832, or EORTC-58881 Between 1971 and 1998 (NCT01298388) | European Organisation for Research and Treatment of Cancer - EORTC | 2011-07-01 |
| Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531 (NCT01407757) | Children's Oncology Group | 2011-07-01 |
| S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy (NCT01360125) | SWOG Cancer Research Network | 2011-06-01 |
| Use of Lipid Emulsion or Nanoemulsion of Propofol on Children Undergoing Ambulatory Invasive Procedures. (NCT01326078) | Cristália Produtos Químicos Farmacêuticos Ltda. | 2011-06-01 |
| Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia (NCT01185886) | European Organisation for Research and Treatment of Cancer - EORTC | 2011-06-01 |
| Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in Remission (NCT01020734) | Asan Medical Center | 2011-05-01 |
| Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors (NCT01323920) | Dana-Farber Cancer Institute | 2011-05-01 |
| Biomarker Study in Bone Marrow Samples From Patients With T-Cell Acute Lymphoblastic Leukemia (NCT01295476) | Children's Oncology Group | 2011-04-01 |
| AMG 319 Lymphoid Malignancy FIH (NCT01300026) | Amgen | 2011-04-01 |
| Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2 (NCT01200485) | M.D. Anderson Cancer Center | 2011-04-01 |
| Biomarkers in Predicting Response to Treatment in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia (NCT01321385) | Children's Oncology Group | 2011-03-01 |
| Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies (NCT01009931) | Rutgers, The State University of New Jersey | 2011-03-01 |
| S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid Leukemia (NCT01338974) | SWOG Cancer Research Network | 2011-03-01 |
| Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (NCT01289457) | M.D. Anderson Cancer Center | 2011-02-02 |
| Biomarkers in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia (NCT01298414) | Children's Oncology Group | 2011-02-01 |
| Biomarkers in Samples of Bone Marrow From Patients With Acute Myeloid Leukemia (NCT01290107) | Children's Oncology Group | 2011-02-01 |
| Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia (NCT01284010) | Alliance for Clinical Trials in Oncology | 2011-02-01 |
| A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediatric Patients With Solid Tumors and Leukemias (NCT01287104) | National Cancer Institute (NCI) | 2011-01-29 |
| Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease (NCT00448201) | UNC Lineberger Comprehensive Cancer Center | 2011-01-07 |
| Dasatinib Combination Therapy With the Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML) (NCT01218477) | Bristol-Myers Squibb | 2011-01-01 |
| Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia (NCT01657955) | Shandong Lanjin Pharmaceuticals Co.,Ltd | 2011-01-01 |
| Sorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic Syndrome (NCT01254890) | M.D. Anderson Cancer Center | 2011-01-01 |
| Single Agent Lenalidomide in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (NCT01401322) | Stanford University | 2011-01-01 |
| Phase l/II Study of Ruxolitinib for Acute Leukemia (NCT01251965) | M.D. Anderson Cancer Center | 2010-12-01 |
| A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy (NCT00558675) | Mirror Biologics, Inc. | 2010-12-01 |
| Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant (NCT01118013) | Alliance for Clinical Trials in Oncology | 2010-12-01 |
| Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic Leukemia (NCT01085617) | University College, London | 2010-12-01 |
| Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL) (NCT01168921) | M.D. Anderson Cancer Center | 2010-11-03 |
| Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia (NCT01229956) | Children's Oncology Group | 2010-11-01 |
| Drug Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia (NCT01150058) | Children's Oncology Group | 2010-11-01 |
| Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia (NCT01247584) | Children's Oncology Group | 2010-11-01 |
| Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease (NCT01249820) | Radboud University Medical Center | 2010-11-01 |
| Biomarkers in Tissue Samples From Patients With Acute Promyelocytic Leukemia (NCT01232855) | Children's Oncology Group | 2010-11-01 |
| Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations (NCT00943943) | M.D. Anderson Cancer Center | 2010-10-29 |
| A Phase I Study of SB939 in Pediatric Patients With Refractory Solid Tumours and Leukemia (NCT01184274) | NCIC Clinical Trials Group | 2010-10-01 |
| Biomarker Study in Tissue Samples From Patients With Acute Myeloid Leukemia (NCT01232842) | Children's Oncology Group | 2010-10-01 |
| Everolimus MICE-regimen in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT01154439) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2010-10-01 |
| Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease (NCT00871702) | Washington University School of Medicine | 2010-10-01 |
| Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL (NCT01228331) | Universitätsklinikum Hamburg-Eppendorf | 2010-10-01 |
| Italian Platelet Technology Assessment Study (NCT01642563) | Centro Nazionale Sangue | 2010-10-01 |
| Early Detection of Anthracycline Cardiotoxicity by Echocardiographic Analysis of Myocardial Deformation in 2D Strain (NCT01212926) | University Hospital, Bordeaux | 2010-09-28 |
| INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease (NCT01164163) | Children's Oncology Group | 2010-09-01 |
| Rituximab for Patients With Relapsed Acute Lymphoblastic Leukemia (NCT01230788) | Emory University | 2010-09-01 |
| Prophylactic White Cell Transfusions Versus Therapeutic White Cell Transfusions in Patients With Leukemia (NCT01204788) | M.D. Anderson Cancer Center | 2010-09-01 |
| To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer (NCT01222780) | Acrotech Biopharma Inc. | 2010-09-01 |
| S0910 Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT00945815) | SWOG Cancer Research Network | 2010-09-01 |
| A Novel Magnetic Needle Using Iron Oxide Nanoparticles for the Detection of Leukemia (NCT01411904) | University of New Mexico | 2010-08-01 |
| Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia (NCT01653613) | Eastern Cooperative Oncology Group | 2010-08-01 |
| Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers (NCT01135329) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2010-08-01 |
| 4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies (NCT01139151) | M.D. Anderson Cancer Center | 2010-08-01 |
| Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation (NCT01116232) | Barbara Ann Karmanos Cancer Institute | 2010-08-01 |
| Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell Transplantation (NCT01138579) | Technical University of Munich | 2010-08-01 |
| Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer (NCT01164709) | Swiss Cancer Institute | 2010-07-01 |
| Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study (NCT01139476) | National Cancer Institute (NCI) | 2010-06-15 |
| Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies (NCT01094860) | M.D. Anderson Cancer Center | 2010-06-08 |
| Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based Therapy (NCT01145469) | Eastern Cooperative Oncology Group | 2010-06-01 |
| Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia (NCT01162031) | Stanford University | 2010-06-01 |
| A Safety and Tolerability Study of PCI-24781 in Subjects With Cancer (NCT01149668) | Pharmacyclics LLC. | 2010-06-01 |
| International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia (NCT01117441) | University Hospital Schleswig-Holstein | 2010-06-01 |
| S9031-S9126-S9333-S9500-B Biomarker Expression in Patients With Acute Myeloid Leukemia (NCT01059734) | SWOG Cancer Research Network | 2010-06-01 |
| Obatoclax Mesylate in Samples From Young Patients With Acute Myeloid Leukemia (NCT01150656) | Children's Oncology Group | 2010-06-01 |
| Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL) (NCT01191541) | Xiaofan Zhu | 2010-05-01 |
| Prognostic Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia (NCT01245231) | Children's Oncology Group | 2010-05-01 |
| Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group (NCT01117168) | Children's Oncology Group | 2010-04-30 |
| Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT00963274) | Virginia Commonwealth University | 2010-04-26 |
| Fludarabine, Bendamustine, and Rituximab (FBR) for Relapsed Chronic Lymphocytic Leukemia (CLL) (NCT01096992) | M.D. Anderson Cancer Center | 2010-04-19 |